Phase
Condition
N/ATreatment
Nirsevimab
Clinical Study ID
Ages < 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Case patients
Age <12 months
Diagnosis of LRTI (i.e., bronchiolitis and/or pneumonia) at admission
Positive RSV PCR on nasopharyngeal swab Control patients
Age <12 months
Diagnosis of LRTI (i.e., bronchiolitis and/or pneumonia) at admission
Hospitalized for conditions other than respiratory infections
Exclusion
Exclusion Criteria:
Parental refusal
Previous immunization with Palivizumab
Previous maternal RSV vaccine immunization during pregnancy
Study Design
Connect with a study center
SOC Pediatria Ospedale Santa Maria Annunziata
Bagno a Ripoli, Firenze 50012
ItalyActive - Recruiting
SOC Pediatria Ospedale San Donato
Arezzo, 52100
ItalyActive - Recruiting
SOC Neonatologia e Terapia Intensiva Neonatale, Ospedale San Giovanni Di Dio
Firenze, 50134
ItalyActive - Recruiting
Meyer Children's Hospital IRCCS
Florence, 50139
ItalyActive - Recruiting
Azienda Ospedaliero Universitaria Pisana
Pisa, 56123
ItalyActive - Recruiting
SOC Pediatria e Neonatologia Ospedale San Jacopo
Pistoia, 51100
ItalyActive - Recruiting
SOC Pediatria e Neonatologia Ospedale Santo Stefano
Prato, 59100
ItalyActive - Recruiting
SOC Pediatria AOU Senese
Siena, 53100
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.